Insider trade

Solventum (SOLV): Officer exercised options on 3,811 shares

Marcela A. Kirberger, Officer at Solventum, reported an option exercise of 3,811 shares.

3,811
Shares
Traded
Dec 1, 2025
Filed
Dec 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 10, 2025FDAFDA device clearance: Tegaderm Post-Op Transparent Antimicrobial Dressing
  2. Oct 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 21, 2025, Solventum Corporation (the “Company”) announced that Heather Knight has been appointed to serve in the newly created role of Chief Commercial Officer of the Company, effective as of November 10, 2025.”
  3. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 13, 20255% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 7.4%

What came next

  1. Dec 31, 2025CongressDisclosed sale of SOLV — reported range $15,001 - $50,000
  2. Jan 27, 20265% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 8.8%
  3. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
  4. Mar 10, 2026Insider · 10 days before an 8-KDirector purchased ~$100K of SOLV shares in the open market
  5. Mar 13, 2026FDAFDA device clearance: Promogran Prisma™ Collagen Matrix with ORC and Silver
  6. Mar 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.”
  7. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Solventum

For Solventum, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOLV page.

How this filing works

Explore the data

Common questions

Which Solventum (SOLV) insider traded, and how much?

Marcela A. Kirberger, Officer at Solventum, reported an option exercise of 3,811 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Dec 1, 2025. Filed: Dec 4, 2025. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Solventum recently?

For Solventum, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the SOLV page.

Does this mean SOLV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Solventum

Everything OQRO holds on this company is on its SOLV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data